Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ansamycin-based Hsp90 inhibitor characterized by Conforma at AACR meeting

July 21, 2003

Selective CDK inhibitor JNJ-7706621 as potential antitumor development candidate

July 21, 2003

BTG to evaluate BGC-9331 as a first-line treatment for gastric cancer

July 21, 2003

Promising preclinical data reported for novel histone deacetylase inhibitor

July 21, 2003

Antiangiogenic MMP inhibitor designed at Kolon

July 21, 2003

Orally active taxane derivative MAC-321 demonstrates broad therapeutic potential

July 21, 2003

Novel FTase inhibitors in early development at Janssen

July 21, 2003

Kyowa Hakko and Fuji researchers identify 1,3,4-thiadiazole-based antitumor agents

July 21, 2003

New metabolically stable antiandrogens prepared and tested at Chugai

July 21, 2003

E.C. awards Aplidin orphan drug status

July 18, 2003

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...